4.2 Article

Do PACS1 variants impeding adaptor protein binding predispose to syndromic intellectual disability?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Genetics & Heredity

Expanding the clinical spectrum associated with the PACS1 p.Arg203Trp mutational hot-spot: Two additional Italian patients

Lucia Pia Bruno et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Genetics & Heredity

Functional genomic analysis delineates regulatory mechanisms of GWAS-identified bipolar disorder risk variants

Rui Chen et al.

Summary: The study identified 16 functional SNPs in 9 risk loci that disrupted the binding of 7 transcription factors, such as CTCF and REST. Potential target genes regulated by these functional SNPs in the human brain were identified through eQTL analysis. Dysregulation of target genes of the identified TF binding-disrupting SNPs was shown in BD patients compared with controls, and overexpression of PACS1 reduced dendritic spine density, revealing possible biological mechanisms of these functional SNPs in BD.

GENOME MEDICINE (2022)

Article Biochemistry & Molecular Biology

The Okur-Chung Neurodevelopmental Syndrome Mutation CK2K198R Leads to a Rewiring of Kinase Specificity

Danielle M. Caefer et al.

Summary: Okur-Chung Neurodevelopmental Syndrome (OCNDS) is a disease caused by mutations in the CSNK2A1 gene, resulting in a shift in substrate specificity of protein kinase CK2. Researchers developed a scoring method to predict changes in phosphorylation sites in the mutant CK2 and applied it to axonally localized ion channels to uncover potential alterations in the phosphoproteome associated with OCNDS. This study provides insights into the impact of the CK2 mutation and its implications for OCNDS.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Review Biochemistry & Molecular Biology

Molecular Basis of the Schuurs-Hoeijmakers Syndrome: What We Know about the Gene and the PACS-1 Protein and Novel Therapeutic Approaches

Maria Arnedo et al.

Summary: The Schuurs-Hoeijmakers syndrome is a rare autosomal dominant disease caused by mutations in the PACS1 gene. It is characterized by neurodevelopment delay, seizures, and a recognizable facial phenotype. Targeting the client proteins of the mutated protein could be a potential therapeutic approach to reduce its toxic effect.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Genetics & Heredity

De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway

Maria Asif et al.

Summary: Mutations in the CSNK2B gene cause a new craniodigital syndrome distinguished from POBINDS by disrupting the canonical Wnt signaling pathway in a dominant-negative manner.

HUMAN GENETICS AND GENOMICS ADVANCES (2022)

Review Genetics & Heredity

Schuurs-Hoeijmakers Syndrome (PACS1 Neurodevelopmental Disorder): Seven Novel Patients and a Review

Jair Tenorio-Castano et al.

Summary: Schuurs-Hoeijmakers syndrome is a rare disorder characterized by intellectual disability, abnormal craniofacial features and congenital malformations. It is caused by pathogenic variants in the PACS1 gene, which is a trans-Golgi-membrane traffic regulator.
Article Genetics & Heredity

De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy

Muhammad A. Usmani et al.

Summary: De novo and bi-allelic variants in the AP1G1 gene are associated with neurodevelopmental disorders across diverse populations, leading to intellectual disabilities, epilepsy, and developmental delay. This is due to the impact on the endosome recycling pathway and altered levels of the AP1 gamma 1 protein, affecting intracellular vesicle formation.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Article Genetics & Heredity

PACS1-Neurodevelopmental disorder: clinical features and trial readiness

Abigail Van Nuland et al.

Summary: The study shows that PACS1-NDD is a moderately-severe intellectual disability syndrome with a high prevalence of seizures, but seizures are not a defining or primary feature of the disorder.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Genetics & Heredity

A Novel Multi-Exon Deletion of PACS1 in a Three-Generation Pedigree: Supplements to PACS1 Neurodevelopmental Disorder Spectrum

Yuan Liu et al.

Summary: PACS1 neurodevelopmental disorder is a rare genetic disorder characterized by intellectual disability and developmental delay. The pathogenesis is associated with specific missense mutations in the PACS1 gene. A novel multi-exon deletion in PACS1 was identified in a three-generation family, shedding light on the relationship between this deletion variant and typical symptoms.

FRONTIERS IN GENETICS (2021)

Review Genetics & Heredity

Prenatal and postnatal diagnosis of Schuurs-Hoeijmakers syndrome: Case series and review of the literature

Mimi Tin-Yan Seto et al.

Summary: Schuurs-Hoeijmakers syndrome (SHS) is a rare syndrome caused by a de novo variant in the PACS1 gene. It is characterized by typical facial features, developmental delay, intellectual disability, and multiple malformations, with distinct diagnostic features before and after birth. Use of exome sequencing has aided in diagnosing SHS and expanding the understanding of the clinical phenotype associated with pathogenic PACS1 variants.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Genetics & Heredity

Interpretable Clinical Genomics with a Likelihood Ratio Paradigm

Peter N. Robinson et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2020)

Article Genetics & Heredity

Mutation of PACS1: the milder end of the spectrum

Antonio Martinez-Monseny et al.

CLINICAL DYSMORPHOLOGY (2018)

Article Urology & Nephrology

Phenotypic Spectrum of Children with Nephronophthisis and Related Ciliopathies

Jens Koenig et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Article Genetics & Heredity

Recurrent De Novo Mutations in PACS1 Cause Defective Cranial-Neural-Crest Migration and Define a Recognizable Intellectual-Disability Syndrome

Janneke H. M. Schuurs-Hoeijmakers et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2012)

Article Biochemistry & Molecular Biology

A PACS-1, GGA3 and CK2 complex regulates CI-MPR trafficking

Gregory K. Scott et al.

EMBO JOURNAL (2006)